Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone in Leydig Cell Proliferation
NCT01206270Phase 3Completed
- Sponsor
- Sapienza University of Rome
- Start
- Jun 2009
- Primary completion
- Jun 2017
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of testosterone undecanoate in Leydig cell hyperplasia (LCH), sponsored by Sapienza University of Rome. Started Jun 2009; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Leydig cell hyperplasia (LCH)
Beyond the preview
Go deeper on NCT01206270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206270.